Fanming Kong

763 total citations
61 papers, 515 citations indexed

About

Fanming Kong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fanming Kong has authored 61 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Fanming Kong's work include Lung Cancer Research Studies (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Gastric Cancer Management and Outcomes (10 papers). Fanming Kong is often cited by papers focused on Lung Cancer Research Studies (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Gastric Cancer Management and Outcomes (10 papers). Fanming Kong collaborates with scholars based in China, Macao and Canada. Fanming Kong's co-authors include Yingjie Jia, Xiaojiang Li, Honggen Liu, Rongxiu Zheng, Lu Zhao, Dou Zhang, Na Wang, Xiaoqun Wang, Fangfang Gao and Jianchun Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Medicine.

In The Last Decade

Fanming Kong

57 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanming Kong China 12 226 180 113 96 87 61 515
Liping Yang China 11 248 1.1× 213 1.2× 89 0.8× 137 1.4× 102 1.2× 21 578
Zhen Zhu China 12 268 1.2× 113 0.6× 70 0.6× 124 1.3× 61 0.7× 23 464
Ming Ma China 14 289 1.3× 127 0.7× 59 0.5× 163 1.7× 100 1.1× 32 530
Gaolei Liu China 12 395 1.7× 241 1.3× 161 1.4× 206 2.1× 70 0.8× 28 699
Aitor Benedicto Spain 13 206 0.9× 183 1.0× 57 0.5× 89 0.9× 117 1.3× 26 579
Qingqu Guo China 14 326 1.4× 247 1.4× 76 0.7× 146 1.5× 65 0.7× 27 613
Jufeng Guo China 17 373 1.7× 204 1.1× 87 0.8× 202 2.1× 154 1.8× 33 673
Xiaolong Ma China 17 388 1.7× 99 0.6× 105 0.9× 136 1.4× 96 1.1× 28 621

Countries citing papers authored by Fanming Kong

Since Specialization
Citations

This map shows the geographic impact of Fanming Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanming Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanming Kong more than expected).

Fields of papers citing papers by Fanming Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanming Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanming Kong. The network helps show where Fanming Kong may publish in the future.

Co-authorship network of co-authors of Fanming Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Fanming Kong. A scholar is included among the top collaborators of Fanming Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanming Kong. Fanming Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, X, Linlin Zhao, Fangfang Gao, et al.. (2025). HER3-targeting Antibody-drug Conjugates Therapy for Solid Tumors: Recent Advances and Future Potentials. Current Medicinal Chemistry. 33(10). 1888–1899. 1 indexed citations
2.
Wang, Na, et al.. (2024). Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review. International Immunopharmacology. 141. 112903–112903. 3 indexed citations
3.
Wang, Xuerui, et al.. (2024). Antibody–drug conjugates treatment of small cell lung cancer: advances in clinical research. Discover Oncology. 15(1). 327–327. 5 indexed citations
4.
Sun, Yidan, Xin Zhang, Dan Yi, et al.. (2024). ADCY4 promotes brain metastasis in small cell lung cancer and is associated with energy metabolism. Heliyon. 10(7). e28162–e28162. 1 indexed citations
5.
6.
Zhu, Meiying, et al.. (2024). Treatment Advances in Lung Cancer with Leptomeningeal Metastasis. Current Cancer Drug Targets. 24(9). 910–919. 3 indexed citations
7.
Sun, Yidan, et al.. (2024). Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma. The Clinical Respiratory Journal. 18(5). e13755–e13755. 2 indexed citations
8.
Wang, Mengchao, et al.. (2023). Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma. Frontiers in Oncology. 13. 1197698–1197698. 3 indexed citations
9.
10.
Zhao, Lu, et al.. (2023). Advances in immune checkpoint inhibitors therapy for small cell lung cancer. Cancer Medicine. 12(10). 11097–11106. 7 indexed citations
11.
Kong, Fanming, Chaoran Wang, Jing Zhang, et al.. (2023). Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice. Chinese Herbal Medicines. 15(4). 485–495. 26 indexed citations
12.
Zhao, Lu, et al.. (2023). Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis. Translational Oncology. 39. 101832–101832. 8 indexed citations
13.
Wang, Na, et al.. (2023). Research progress on the immunomodulatory mechanism of acupuncture in tumor immune microenvironment. Frontiers in Immunology. 14. 1092402–1092402. 6 indexed citations
14.
Kong, Fanming, Na Wang, Fangfang Gao, et al.. (2023). The clinical application of atorvastatin in patients with small-cell lung cancer with dyslipidemia. Journal of Cancer Research and Clinical Oncology. 149(15). 13697–13704.
15.
Kong, Fanming, et al.. (2022). The Clinical Observation of Acupuncture Combined With Antiemetic Drugs in the Prevention and Treatment of CINV in Breast Cancer Patients. Frontiers in Oncology. 12. 888651–888651. 5 indexed citations
16.
Kong, Fanming, et al.. (2021). Hopes and failures in front-line advanced HER2-positive gastric cancer therapy. Anti-Cancer Drugs. 32(7). 675–680. 2 indexed citations
17.
Kong, Fanming, et al.. (2021). Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance. Frontiers in Oncology. 11. 739191–739191. 8 indexed citations
18.
Liu, Honggen, Yong Liu, Fanming Kong, et al.. (2015). Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer. Journal of the American College of Surgeons. 221(2). 579–590. 17 indexed citations
19.
Liu, Honggen, Yunchao Zhang, Fanming Kong, et al.. (2015). GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Tumor Biology. 37(1). 503–510. 16 indexed citations
20.
Kong, Fanming, Fangfang Gao, Honggen Liu, et al.. (2015). Metformin use improves the survival of diabetic combined small-cell lung cancer patients. Tumor Biology. 36(10). 8101–8106. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liping Yang Breakdown of academic impact, for papers by Zhen Zhu Breakdown of academic impact, for papers by Ming Ma Breakdown of academic impact, for papers by Gaolei Liu Breakdown of academic impact, for papers by Aitor Benedicto Breakdown of academic impact, for papers by Qingqu Guo Breakdown of academic impact, for papers by Jufeng Guo Breakdown of academic impact, for papers by Xiaolong Ma
Rankless by CCL
2026